ALNY: Alnylam Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ALNY: Alnylam Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 34,128.35
Enterprise Value ($M) 35,476.45
Book Value ($M) 32.35
Book Value / Share 0.25
Price / Book 1,054.84
NCAV ($M) -817.26
NCAV / Share -6.34
Price / NCAV -41.76

Profitability (mra)
Return on Invested Capital (ROIC) -0.12
Return on Assets (ROA) -0.09
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.69
Current Ratio 2.75

Balance Sheet (mrq) ($M)
Current Assets 3,355.42
Assets 4,205.04
Liabilities 4,172.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Fmr Llc 11.48 11.23
7 days ago 13G/A Wellington Management Group Llp 3.91 -30.80
07-05 13G/A Baillie Gifford & Co 4.77 -13.41
02-13 13G/A Vanguard Group Inc 9.52 3.80
02-09 13G/A Capital World Investors 13.10 -1.18
01-26 13G/A BlackRock Inc. 6.80 -1.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ____________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Ma
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K _____________________________________________________________________________________________ ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-14 116,479 524,135 22.22
2024-11-13 107,665 516,937 20.83
2024-11-12 175,809 816,357 21.54
2024-11-11 113,316 750,202 15.10

(click for more detail)

Similar Companies
ALKS – Alkermes plc ALLK – Allakos Inc.
ALLO – Allogene Therapeutics, Inc. ALXO – ALX Oncology Holdings Inc.
AMGN – Amgen Inc.


Financial data and stock pages provided by
Fintel.io